Symbol Name ID |
Irs3
insulin receptor substrate 3 MGI:1194882 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Irs1tm1Jos/Irs1tm1Jos Irs3tm1Lhd/Irs3tm1Lhd involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 |
abnormal gonadal fat pad morphology | J:80976 |
decreased circulating free fatty acids level | J:80976 | |
decreased circulating leptin level | J:80976 | |
decreased circulating triglyceride level | J:80976 | |
decreased triglyceride level | J:80976 | |
decreased white adipose tissue amount | J:80976 | |
hyperglycemia | J:80976 | |
impaired glucose tolerance | J:80976 | |
increased circulating insulin level | J:80976 | |
increased pancreatic beta cell mass | J:80976 | |
insulin resistance | J:80976 | |
normal liver/biliary system phenotype | J:80976 | |
normal mortality/aging | J:80976 | |
pancreatic islet hyperplasia | J:80976 | |
postnatal growth retardation | J:80976 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|